|
CDK12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64501745558709E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.69939634481398E-11 |
| Normal-vs-Stage2 |
4.94619999957813E-07 |
| Normal-vs-Stage3 |
1.21710419520582E-11 |
| Normal-vs-Stage4 |
3.72739616949502E-11 |
| Stage1-vs-Stage2 |
9.270400E-01 |
| Stage1-vs-Stage3 |
1.739160E-01 |
| Stage1-vs-Stage4 |
2.345600E-02 |
| Stage2-vs-Stage3 |
3.867200E-01 |
| Stage2-vs-Stage4 |
1.200600E-01 |
| Stage3-vs-Stage4 |
4.056800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.18807219407336E-13 |
| Normal-vs-AfricanAmerican |
5.387800E-04 |
| Normal-vs-Asian |
4.17540000352545E-08 |
| Caucasian-vs-AfricanAmerican |
3.426600E-01 |
| Caucasian-vs-Asian |
6.872400E-01 |
| AfricanAmerican-vs-Asian |
2.569200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61569663098749E-11 |
| Normal-vs-Female |
5.63527002839237E-12 |
| Male-vs-Female |
5.982300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.81860012896607E-10 |
| Normal-vs-Age(41-60Yrs) |
1.02869934792693E-11 |
| Normal-vs-Age(61-80Yrs) |
1.76429981735282E-10 |
| Normal-vs-Age(81-100Yrs) |
1.355020E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.599800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.259180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.716000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.811000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.337600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.542800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.967700E-02 |
| Classical-VS-Follicular |
6.529700E-02 |
| Classical-VS-Other |
1.151780E-01 |
| Classical-VS-Normal |
2.34420260980528E-11 |
| Tall-VS-Follicular |
5.749400E-01 |
| Tall-VS-Other |
5.046200E-01 |
| Tall-VS-Normal |
4.69670002889444E-09 |
| Follicular-VS-Other |
3.997000E-01 |
| Follicular-VS-Normal |
7.17359949220508E-10 |
| Other-VS-Normal |
4.377700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9160228958981E-12 |
| Normal-vs-N1 |
3.96339999708673E-08 |
| N0-vs-N1 |
6.164200E-01 |
|
|
